BOSTON, MA--(Marketwire - April 02, 2008) - While the trend to outsource key elements of drug development to service providers could slow down due in part to rising operating costs worldwide, drug developers need to adopt an outsourcing strategy that optimizes their skill sets, according to the Tufts Center for the Study of Drug Development.